Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Autism ; 6: 66, 2015.
Article in English | MEDLINE | ID: mdl-26697163

ABSTRACT

BACKGROUND: Fragile X syndrome (FXS) is a neurodevelopmental disorder whose biochemical manifestations involve dysregulation of mGluR5-dependent pathways, which are widely modeled using cultured neurons. In vitro phenotypes in cultured neurons using standard morphological, functional, and chemical approaches have demonstrated considerable variability. Here, we study transcriptomes obtained in situ in the intact brain tissues of a murine model of FXS to see how they reflect the in vitro state. METHODS: We used genome-wide mRNA expression profiling as a robust characterization tool for studying differentially expressed pathways in fragile X mental retardation 1 (Fmr1) knockout (KO) and wild-type (WT) murine primary neuronal cultures and in embryonic hippocampal and cortical murine tissue. To study the developmental trajectory and to relate mouse model data to human data, we used an expression map of human development to plot murine differentially expressed genes in KO/WT cultures and brain. RESULTS: We found that transcriptomes from cell cultures showed a stronger signature of Fmr1KO than whole tissue transcriptomes. We observed an over-representation of immunological signaling pathways in embryonic Fmr1KO cortical and hippocampal tissues and over-represented mGluR5-downstream signaling pathways in Fmr1KO cortical and hippocampal primary cultures. Genes whose expression was up-regulated in Fmr1KO murine cultures tended to peak early in human development, whereas differentially expressed genes in embryonic cortical and hippocampal tissues clustered with genes expressed later in human development. CONCLUSIONS: The transcriptional profile in brain tissues primarily centered on immunological mechanisms, whereas the profiles from cell cultures showed defects in neuronal activity. We speculate that the isolation and culturing of neurons caused a shift in neurological transcriptome towards a "juvenile" or "de-differentiated" state. Moreover, cultured neurons lack the close coupling with glia that might be responsible for the immunological phenotype in the intact brain. Our results suggest that cultured cells may recapitulate an early phase of the disease, which is also less obscured with a consequent "immunological" phenotype and in vivo compensatory mechanisms observed in the embryonic brain. Together, these results suggest that the transcriptome of cultured primary neuronal cells, in comparison to whole brain tissue, more robustly demonstrated the difference between Fmr1KO and WT mice and might reveal a molecular phenotype, which is typically hidden by compensatory mechanisms present in vivo. Moreover, cultures might be useful for investigating the perturbed pathways in early human brain development and genes previously implicated in autism.

2.
Annu Rev Neurosci ; 35: 417-43, 2012.
Article in English | MEDLINE | ID: mdl-22483044

ABSTRACT

Fragile X is the most common known inherited cause of intellectual disability and autism, and it typically results from transcriptional silencing of FMR1 and loss of the encoded protein, FMRP (fragile X mental retardation protein). FMRP is an mRNA-binding protein that functions at many synapses to inhibit local translation stimulated by metabotropic glutamate receptors (mGluRs) 1 and 5. Recent studies on the biology of FMRP and the signaling pathways downstream of mGluR1/5 have yielded deeper insight into how synaptic protein synthesis and plasticity are regulated by experience. This new knowledge has also suggested ways that altered signaling and synaptic function can be corrected in fragile X, and human clinical trials based on this information are under way.


Subject(s)
Brain/physiopathology , Fragile X Mental Retardation Protein/physiology , Fragile X Syndrome/physiopathology , Synapses/physiology , Animals , Brain/metabolism , Disease Models, Animal , Fragile X Syndrome/metabolism , Gene Expression Regulation/physiology , Humans , Models, Biological , Nerve Tissue Proteins/biosynthesis , Neuronal Plasticity/physiology , Protein Biosynthesis/physiology , RNA/metabolism , Receptors, Metabotropic Glutamate/metabolism , Signal Transduction/physiology , Synapses/metabolism
3.
J Neurosci ; 29(11): 3529-37, 2009 Mar 18.
Article in English | MEDLINE | ID: mdl-19295158

ABSTRACT

Although chronic cocaine-induced changes in dendritic spines on nucleus accumbens (NAc) neurons have been correlated with behavioral sensitization, the molecular pathways governing these structural changes, and their resulting behavioral effects, are poorly understood. The transcription factor, nuclear factor kappa B (NFkappaB), is rapidly activated by diverse stimuli and regulates expression of many genes known to maintain cell structure. Therefore, we evaluated the role of NFkappaB in regulating cocaine-induced dendritic spine changes on medium spiny neurons of the NAc and the rewarding effects of cocaine. We show that chronic cocaine induces NFkappaB-dependent transcription in the NAc of NFkappaB-Lac transgenic mice. This induction of NFkappaB activity is accompanied by increased expression of several NFkappaB genes, the promoters of which show chromatin modifications after chronic cocaine exposure consistent with their transcriptional activation. To study the functional significance of this induction, we used viral-mediated gene transfer to express either a constitutively active or dominant-negative mutant of Inhibitor of kappa B kinase (IKKca or IKKdn), which normally activates NFkappaB signaling, in the NAc. We found that activation of NFkappaB by IKKca increases the number of dendritic spines on NAc neurons, whereas inhibition of NFkappaB by IKKdn decreases basal dendritic spine number and blocks the increase in dendritic spines after chronic cocaine. Moreover, inhibition of NFkappaB blocks the rewarding effects of cocaine and the ability of previous cocaine exposure to increase an animal's preference for cocaine. Together, these studies establish a direct role for NFkappaB pathways in the NAc to regulate structural and behavioral plasticity to cocaine.


Subject(s)
Cocaine/administration & dosage , NF-kappa B/physiology , Neurons/drug effects , Neurons/physiology , Reward , Signal Transduction/drug effects , Signal Transduction/physiology , Animals , Cells, Cultured , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neurons/ultrastructure , Nucleus Accumbens/cytology , Nucleus Accumbens/drug effects , Nucleus Accumbens/physiology , PC12 Cells , Rats
4.
J Clin Epidemiol ; 60(7): 670-679, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17573982

ABSTRACT

OBJECTIVE: The prognostic value of Patient-Reported Outcomes (PRO) in predicting mortality during treatment of multiple myeloma (MM) patients was assessed using partial least square (PLS) regression, a statistical method that is well-adapted for highly correlated data. STUDY DESIGN AND SETTING: Four PRO measures, The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30, the EORTC QLQ-MY24, the FACIT-Fatigue scale, and the FACT/GOG-Ntx scale, were administered during a trial designed to evaluate the efficacy and safety of bortezomib (VELCADE 1.3mg/m(2)) in MM patients (N=202). Clinical and PRO data were analyzed for predictive value by univariate and multivariate logistic regression methods and then by PLS regression. RESULTS: Fifteen baseline PRO parameters were significant in predicting mortality during treatment when univariate logistic regression was used. In contrast, only two variables were retained in the multivariate analysis, as correlated variables were excluded from the model. Using PLS regression, 14 of the 21 PRO predictors were significant in predicting mortality. Clinical and PRO data used together increased the predictive power of all models compared to clinical data alone. CONCLUSION: The prognostic value of PRO was established and was more informative using PLS regression. PLS regression may therefore be a valuable method for analyzing PRO data.


Subject(s)
Multiple Myeloma/mortality , Adult , Aged , Aged, 80 and over , Cognition , Data Interpretation, Statistical , Emotions , Fatigue/psychology , Female , Humans , Least-Squares Analysis , Logistic Models , Male , Middle Aged , Multiple Myeloma/drug therapy , Multiple Myeloma/physiopathology , Patient Participation , ROC Curve , Recurrence , Surveys and Questionnaires , Treatment Outcome
5.
Dev Dyn ; 231(1): 122-7, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15305292

ABSTRACT

Nuclear factor-kappa B (NF-kB) transcriptional activity is induced by numerous stimuli. To identify tissues exhibiting NF-kB transcriptional activity during development, we analyzed transgenic reporter mice that express beta-galactosidase from an NF-kB-responsive element. We report that NF-kB activation is widespread and present in numerous epithelial structures and within vasculature. Several regions of the developing central nervous system, including the roof plate and floor plate of the midbrain, show prominent NF-kB activation. To assess the role of the TRAF6 adaptor protein in developmental NF-kB activity, we analyzed NF-kB activation in reporter mice rendered null for TRAF6. Deletion of TRAF6 resulted in the loss of NF-kB activity in epithelia, in vasculature, and in roof and floor plate but had no effect on NF-kB activity developing telencephalon, choroid plexus, cochlear canal, and thymus. These data indicate that NF-kB transcriptional activity is present in a broad range of structures during development and that TRAF6 plays a critical role mediating developmental NF-kB activation in many but not all tissues.


Subject(s)
Blood Vessels/metabolism , Central Nervous System/metabolism , Epithelium/metabolism , Protein Serine-Threonine Kinases/metabolism , TNF Receptor-Associated Factor 6/metabolism , Animals , Blood Vessels/cytology , Blood Vessels/embryology , Central Nervous System/cytology , Central Nervous System/embryology , Choroid Plexus/cytology , Choroid Plexus/embryology , Choroid Plexus/metabolism , Cochlear Duct/cytology , Cochlear Duct/embryology , Cochlear Duct/metabolism , Epithelium/embryology , Mesencephalon/cytology , Mesencephalon/embryology , Mesencephalon/metabolism , Mice , Mice, Transgenic , Telencephalon/cytology , Telencephalon/embryology , Telencephalon/metabolism , Thymus Gland/cytology , Thymus Gland/embryology , Thymus Gland/metabolism , beta-Galactosidase/metabolism , NF-kappaB-Inducing Kinase
6.
J Neurosci ; 23(36): 11373-81, 2003 Dec 10.
Article in English | MEDLINE | ID: mdl-14673001

ABSTRACT

The p75 neurotrophin receptor (p75NTR), a member of the tumor necrosis factor receptor superfamily, facilitates apoptosis during development and after injury to the CNS. The signaling cascades activated by p75NTR that result in apoptosis remain poorly understood. In this study, we show that overexpression of p75NTR in primary cortical neurons, in pheochromocytoma cell line (PC12) cells, and in glioma cells results in activation of Jun kinase (JNK), accumulation of cytochrome c within the cytosol, and activation of caspases 9, 6, and 3. To link p75NTR-dependent JNK activation to mitochondrial cytochrome c release, regulation of BH3-domain-only family members was examined. Transcription of BH3-domain-only family members was not induced by p75NTR, but p75NTR-dependent JNK activation resulted in phosphorylation and oligomerization of the BH3-domain-only family member Bad. Loss of function experiments using Bad dominant negatives or RNA interference demonstrated a requirement for Bad in p75NTR-induced apoptosis. Together, these studies provide the first data linking apoptosis induced by p75NTR to the phosphorylation of BH3-domain-only family members.


Subject(s)
Apoptosis , Carrier Proteins/metabolism , Mitogen-Activated Protein Kinases/metabolism , Neurons/metabolism , Receptors, Nerve Growth Factor/metabolism , Animals , Carrier Proteins/physiology , Caspases/metabolism , Cell Line, Tumor , Cell Survival , Cells, Cultured , Cytochromes c/metabolism , Humans , JNK Mitogen-Activated Protein Kinases , MAP Kinase Signaling System , Mice , Neurons/cytology , Neurons/enzymology , PC12 Cells , Phosphorylation , Rats , Receptor, Nerve Growth Factor , Receptors, Nerve Growth Factor/genetics , Transfection , bcl-Associated Death Protein
7.
J Biol Chem ; 278(31): 28823-30, 2003 Aug 01.
Article in English | MEDLINE | ID: mdl-12750376

ABSTRACT

The epsin N-terminal homology (ENTH) domain is a protein module of approximately 150 amino acids found at the N terminus of a variety of proteins identified in yeast, plants, nematode, frog, and mammals. ENTH domains comprise multiple alpha-helices folded upon each other to form a compact globular structure that has been implicated in interactions with lipids and proteins. In characterizing this evolutionarily conserved domain, we isolated and identified tubulin as an ENTH domain-binding partner. The interaction, which is direct and has a dissociation constant of approximately 1 microm, was observed with ENTH domains of proteins present in various species. Tubulin is co-immunoprecipitated from rat brain extracts with the ENTH domain-containing proteins, epsins 1 and 2, and punctate epsin staining is observed along the microtubule cytoskeleton of dissociated cortical neurons. Consistent with a role in microtubule processes, the over-expression of epsin ENTH domain in PC12 cells stimulates neurite outgrowth. These data demonstrate an evolutionarily conserved property of ENTH domains to interact with tubulin and microtubules.


Subject(s)
Carrier Proteins/chemistry , Monomeric Clathrin Assembly Proteins/chemistry , Neuropeptides/chemistry , Tubulin/metabolism , Vesicular Transport Proteins , Adaptor Proteins, Vesicular Transport , Animals , Binding Sites , Brain Chemistry , Carrier Proteins/metabolism , Conserved Sequence , Humans , Immunosorbent Techniques , Microtubules/chemistry , Microtubules/metabolism , Monomeric Clathrin Assembly Proteins/metabolism , Neurites/physiology , Neurons/chemistry , Neurons/ultrastructure , Neuropeptides/metabolism , Protein Folding , Protein Structure, Secondary , Rats , Recombinant Fusion Proteins , Structural Homology, Protein , Tubulin/analysis
8.
J Neurosci ; 22(19): 8466-75, 2002 Oct 01.
Article in English | MEDLINE | ID: mdl-12351721

ABSTRACT

The function of nuclear factor (NF)-kappaB within the developing and mature CNS is controversial. We have generated transgenic mice to reveal NF-kappaB transcriptional activity in vivo. As expected, constitutive NF-kappaB activity was observed within immune organs, and tumor necrosis factor-inducible NF-kappaB activity was present in mesenchymal cells. Intriguingly, NF-kappaB activity was also prominent in the CNS throughout development, especially within neocortex, olfactory bulbs, amygdala, and hippocampus. NF-kappaB in the CNS was restricted to neurons and blocked by overexpression of dominant-negative NF-kappaB-inducible kinase or the IkappaBalphaM super repressor. Blocking endogenous neuronal NF-kappaB activity in cortical neurons using recombinant adenovirus induced neuronal death, whereas induction of NF-kappaB activity increased levels of anti-apoptotic proteins and was strongly neuroprotective. Together, these data demonstrate a physiological role for NF-kappaB in maintaining survival of central neurons.


Subject(s)
Central Nervous System/metabolism , NF-kappa B/metabolism , Neurons/metabolism , Animals , Cell Survival/physiology , Cells, Cultured , Central Nervous System/cytology , Fibroblasts/cytology , Genes, Reporter , Green Fluorescent Proteins , Inhibitor of Apoptosis Proteins , Kidney/cytology , Kidney/metabolism , Luminescent Proteins/biosynthesis , Luminescent Proteins/genetics , Mice , Mice, Transgenic , NF-kappa B/biosynthesis , NF-kappa B/genetics , Neurons/cytology , Organ Specificity , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Signal Transduction/physiology , Transcription Factor RelA , Transfection , Viral Proteins/metabolism , bcl-X Protein , beta-Galactosidase/biosynthesis , beta-Galactosidase/genetics , NF-kappaB-Inducing Kinase
SELECTION OF CITATIONS
SEARCH DETAIL
...